EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback